Form 4 for ATRC AtriCure, Inc.
Accepted 2021-07-14 00:00:00 ET · period of report 2021-07-12 · accession 0001209191-21-046673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-14 | 2021-07-12 | ATRC | Doraiswamy Vinayak | CSO | S - Sale | $83.12 | -7,672 | 16.9K | -31% | -$637.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-12 | S | D | 7,672 | $83.12 | 16,875 | D | — | — | (F1) These shares were sold pursuant to a 10b5-1 trading plan. (F2) This transaction was executed in multiple trades at prices ranging from $81.36 to $83.96 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |